Teprotumumab, Canagliflozin, and Kevin Pho Top AACE Agenda Teprotumumab, Canagliflozin, and Kevin Pho Top AACE Agenda

Graves ' ophthalmopathy, type 2 diabetes treatment, social media matters, and much more to be featured at Los Angeles conference.Medscape Medical News

Source: Medscape Diabetes Headlines - April 16, 2019 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news